FDA Approves Dolutegravir Tablets for Oral Suspension for Children With HIV

OFFICIALS with the FDA have approved dolutegravir (Tivicay PD, ViiV Healthcare) dispersible tablets for oral suspension for children who are at least 4 weeks of age and weigh at least 3 kg, according to a press release. SOURCE: DRUG TOPICS This approval marks the first ever dispersible tablet formulation of dolutegravir, which are used in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients. Additionally, the approval also expands dolutegravir’s indication for the existing 50-mg film-coated tablets (Tivicay) for use in children weighing 20 kg…

Share
Read More

#Talking COVID-19 With Dr Grant: Are We Doing Enough Testing For COVID-19 In Zimbabwe?

Dr Grant Marewanhema

THE first cases of COVID-19 were confirmed in Wuhan, China,  in December 2019, and a few months later the disease became a worldwide pandemic. To date over 7 million infections have been reported. Zimbabwe has reported 356 cases, which include 4 deaths and 54 recoveries. By Grant Murewanhema Transmission patterns include imported disease, sporadic disease, clusters of disease and community transmission. In community transmission, clusters of cases are reported in the communities without clear linkage to imported cases. Most of the cases reported in Zimbabwe so far have been among…

Share
Read More

Open letter to the Minister of Health From Quarantine

AFTER spending 22 days in captivity we were told that we cannot leave quarantine after testing. The standard published by the government is a maximum of 21, but I am sitting at 25 with cellmates having up to 30 and even more. The reason behind our continued detention being: of the over 100 tests conducted 4 days ago, one inmate has tested positive. We are thus supposed to stay on for another 8 days after which we shall be tested again. The rationale, according to the ministry of health which…

Share
Read More